USPTO Deadlines
Application History
20 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 14, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Nov 8, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Jan 22, 2024 | FINT | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Jan 3, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jan 3, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| May 16, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Apr 26, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Apr 26, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Jan 3, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Jan 3, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Jan 3, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Jul 5, 2022 | RFNT | P | REFUSAL PROCESSED BY IB |
| Jun 14, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jun 14, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Jun 10, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Jun 9, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 7, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 3, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Nov 29, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 25, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids, all for scientific and research purposes
Class 005
Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids, all for medical and veterinary use
Class 042
Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; research, development and bioengineering services relating to lentiviruses; drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services
Classification
International Classes
001
005
042